Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/9/26 18:18 | 10/8/26 | ALKS | Health | Drug | Pharmaceutical Preparations | Reed Joshua | MA | O | SVP,CFO | 1 | M.d | 0 | 0.00 | 0 | 9 | 5 | D | |||||||||||||||
10/2/26 18:22 | 10/2/26 | ALKS | Health | Drug | Pharmaceutical Preparations | Gaffin David Joseph | MA | O | EVP,CLO, | 3 | S | -280 | 45.87 | 0 | -6 | 225 | D | |||||||||||||||
9/1/26 19:08 | 9/1/26 | ALKS | Health | Drug | Pharmaceutical Preparations | Hopkinson Craig C. | MA | O | EVP R,D, | 4 | M.d | 1,105 | 39.48 | 0 | 28 | 68 | 69 | D | ||||||||||||||
9/1/26 19:08 | 9/1/26 | ALKS | Health | Drug | Pharmaceutical Preparations | Hopkinson Craig C. | MA | O | EVP R,D, | 4 | S.d | -1,105 | 39.48 | 0 | -28 | 69 | D | |||||||||||||||
8/17/26 18:53 | 8/17/26 | ALKS | Health | Drug | Pharmaceutical Preparations | Nichols Christian Todd | MA | O | SVP,Chie | 1 | S | -373 | 49.23 | 0 | -8 | 102 | D | |||||||||||||||
8/3/26 19:16 | 8/3/26 | ALKS | Health | Drug | Pharmaceutical Preparations | Snyderman Nancy Lynn Md | D | 2 | M.d | 4,317 | 48.53 | 0 | 89 | 36 | D | |||||||||||||||||
8/3/26 19:16 | 8/3/26 | ALKS | Health | Drug | Pharmaceutical Preparations | Snyderman Nancy Lynn Md | D | 2 | S.d | -4,317 | 48.53 | 0 | -89 | 36 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |